Altimmune Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ALT Nasdaq 2834 http://www.altimmune.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Altimmune Inc

Why Altimmune Stock Is Skyrocketing Today - Sep 19th, 2018 3:16 pm
Altimmune Announces Additional Positive Data from Its Phase 2a Study of NasoVAX Intranasal Influenza Vaccine - Sep 4th, 2018 6:00 am
Altimmune Announces Initial Single-Dose Data from Its NasoShield Phase 1 Study - Aug 31st, 2018 6:00 am
Altimmune, Inc. to Host Earnings Call - Aug 15th, 2018 4:30 am
Altimmune Announces Second Quarter 2018 Financial Results and Provides Corporate Update - Aug 14th, 2018 2:01 pm
Altimmune to Announce Second Quarter 2018 Financial Results on August 15 - Aug 7th, 2018 6:00 am
Altimmune Restructures Financing Agreement with Majority of the Remaining Series B Investors - Jul 12th, 2018 6:00 am
Altimmune Appoints Mitchel Sayare as Executive Chairman of the Board, and Adds José Ochoa to Its Leadership Team as Chief Business Officer - Jul 10th, 2018 6:00 am
Altimmune Restructures Financing Agreement - Jun 22nd, 2018 2:15 pm
Stock Performance Review on Alder Biopharma and Three Other Biotech Stocks - Jun 11th, 2018 5:10 am
U.S. hedge fund Hudson Bay to open London office - sources - Jun 5th, 2018 4:45 am
Does Altimmune Inc’s (NASDAQ:ALT) CEO Salary Reflect Performance? - May 24th, 2018 11:47 am
Gaithersburg biotech faces threat of stock delisting - May 18th, 2018 2:55 pm
Who Are The Major Shareholders Of Altimmune Inc (NASDAQ:ALT)? - May 8th, 2018 4:03 pm
Free Research Report as ChemoCentryx’s Quarterly Revenues Zoomed More than 1000%; Turned Profitable Y-O-Y - Apr 19th, 2018 5:40 am
Here’s What’s Moving Esperion And Altimmune, Inc. - Mar 28th, 2018 9:10 am